Pediatric post-tonsillectomy hemorrhage (PTH) affects up to 6.7% of patients. Nebulized tranexamic acid (nTXA) is low in cost, safe, achieves hemostasis, and decreases the return to the OR (ROR). Only 14% of patients who presented to the ED at a large pediatric emergency department received nTXA.
